Mark Gilbert, PhD, Leanne Picketts, MEd, Anna MacLeod, PhD, and Wendy A. Stewart, MD, MMEd, PhD
This study offers an arts-based tool set capable of being delivered within the familiar medical education setting and established structure of the OSCE.
AMA J Ethics. 2022;24(7):E556-562. doi:
10.1001/amajethics.2022.556.
Miranda B. Olson, MSc, Stacey Springs, PhD, and Jay Baruch, MD
Responsible arts in health research requires interrogating what counts as evidence, especially when the insistence on rigor risks oversimplifying and diminishing what’s ineffable about the arts.
AMA J Ethics. 2022;24(7):E617-621. doi:
10.1001/amajethics.2022.617.
Sarosh Nagar, Leah Z. Rand, PhD, and Aaron S. Kesselheim, MD, JD, MPH
This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.
AMA J Ethics. 2022;24(11):E1083-1090. doi:
10.1001/amajethics.2022.1083.
Artist and researcher Dr Mark Gilbert joins Ethics Talk to discuss arts-based research: what it is, who it’s for, and why we should pay closer attention to it as a method of clinical inquiry.
This article examines conceptual limitations of extant accounts of palliative psychiatry, with a focus on obligations to distinguish among and clearly formulate goals of care.
AMA J Ethics. 2023;25(9):E710-717. doi:
10.1001/amajethics.2023.710.